Artal Group Discloses 10.1% Passive Stake in Solid Biosciences

TL;DR

**Artal Group just revealed a 10.1% passive stake in Solid Biosciences, a bullish signal for the stock.**

AI Summary

Artal International S.C.A. and its affiliated group, including Artal Group S.A. and Invus Public Equities, L.P., reported a significant passive ownership stake in Solid Biosciences Inc. (NASDAQ: SLDB). As of January 11, 2024, this group collectively holds 10,248,300 shares of Solid Biosciences' Common Stock, representing 10.1% of the company's outstanding shares. This matters to investors because it signals a substantial vote of confidence from a large institutional investor, potentially indicating a belief in the company's long-term prospects, but as a passive stake, it doesn't suggest immediate operational changes.

Why It Matters

A large institutional investor taking a significant passive stake can boost investor confidence and potentially attract more attention to the stock, but it doesn't imply active involvement in company management.

Risk Assessment

Risk Level: low — This filing indicates a passive investment, meaning the holder is not seeking to influence management, which generally poses low risk to existing shareholders.

Analyst Insight

A smart investor would note this significant institutional vote of confidence and consider it as a positive data point when evaluating Solid Biosciences Inc., but also understand that this is a passive stake and doesn't signal immediate operational changes or activist intent.

Key Numbers

• 10,248,300 — Shares Beneficially Owned (Total shares of Solid Biosciences Common Stock held by the Artal group)
• 10.1% — Percentage of Class (The Artal group's ownership percentage of Solid Biosciences' Common Stock)
• January 11, 2024 — Date of Event (The date triggering the requirement for this SC 13G filing)

Key Players & Entities

• Artal International S.C.A. (company) — filer of the SC 13G
• Solid Biosciences Inc. (company) — subject company of the filing
• Artal Group S.A. (company) — group member with shared voting/dispositive power
• Invus Public Equities, L.P. (company) — group member with shared voting/dispositive power
• Mr. Amaury Wittouck (person) — group member with shared voting/dispositive power

Forward-Looking Statements

• Solid Biosciences Inc. stock may experience increased investor interest due to the disclosed institutional ownership. (Solid Biosciences Inc.) — medium confidence, target: Next 3-6 months

FAQ

Key Financial Figures

• $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class o

Filing Documents

• d169779dsc13g.htm (SC 13G) — 134KB
• d169779dex991.htm (EX-99.1) — 10KB
• 0001193125-24-012203.txt ( ) — 147KB

(a)

Item 1(a). Name of Issuer: Solid Biosciences Inc. (the Issuer)

(b)

Item 1(b). Address of Issuers Principal Executive Offices: 500 Rutherford Avenue, Third Floor, Charlestown, MA 02129

(a)

Item 2(a). Name of Person Filing:

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence:

(c)

Item 2(c). Citizenship: (i) Invus Public Equities, L.P. (Invus Public Equities) 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Bermuda limited partnership (ii) Invus Public Equities Advisors, LLC (Invus PE Advisors) 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (iii) Artal International S.C.A. (Artal International) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg limited partnership (iv) Artal International Management S.A. (Artal International Management) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg société anonyme (v) Artal Group S.A. (Artal Group) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg société anonyme (vi) Westend S.A. (Westend) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg société anonyme (vii) Stichting Administratiekantoor Westend (the Stichting) Claude Debussylaan, 46, 1082 MD Amsterdam, The Netherlands Citizenship: Netherlands foundation (viii) Mr. Amaury Wittouck Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Belgium The foregoing persons are hereinafter sometimes collectively referred to as the Reporting Persons.

(d)

Item 2(d). Title of Class of Securities: Common Stock, $0.001 par value per share (the Shares)

(e)

Item 2(e). CUSIP Number: 83422E204 10 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): This Item 3 is not applicable. Item 4. (a) Amount beneficially owned: As of the date hereof, Invus Public Equities directly held 2,717,538 Shares. Invus PE Advisors, as the general partner of Invus Public Equities, controls Invus Public Equities and, accordingly, may be deemed to beneficially own the Shares held by Invus Public Equities. The Geneva branch of Artal International, as the managing member of Invus PE Advisors, controls Invus PE Advisors and, accordingly, may be deemed to beneficially own the Shares that Invus PE Advisors may be deemed to beneficially own. Artal International Management, as the managing partner of Artal International, controls Artal International and, accordingly, may be deemed to beneficially own the Shares that Artal International may be deemed to beneficially own. Artal Group, as the sole stockholder of Artal International Management, controls Artal International Management and, accordingly, may be deemed to beneficially own the Shares that Artal International Management may be deemed to beneficially own. Westend, as the parent company of Artal Group, controls Artal Group and, accordingly, may be deemed to beneficially own the Shares that Artal Group may be deemed to beneficially own. The Stichting, as the majority stockholder of Westend, controls Westend and, accordingly, may be deemed to beneficially own the Shares that Westend may be deemed to beneficially own. Mr. Wittouck, as the sole member of the board of the Stichting, controls the Stichting and, accordingly, may be deemed to beneficially own the Shares that the Stichting may be deemed to beneficially own. (b) Percent of class: Each of the Reporting Persons may be deemed to be the beneficial owner of the percentage of Shares listed on such Reporting Persons cover page. Calcula

View Full Filing

View this SC 13G filing on SEC EDGAR